| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-06 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.44 | 0.0002 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |